Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting

Ludwig, H. ✉; Ramasamy, K.; Mateos, M.-V.; Kishore, B.; Gergely, V. [Varga, Gergely (hematológia), author] Belgyógyászati és Hematológiai Klinika (SU / FM / C); Ladicka, M.; Ori, A.; Simoni, L.; Bent-Ennakhil, N.; Stull, D.M.; Gavini, F.; Terpos, E.; Hájek, R.